IDPC sheds light on key political wins including in relation to countering racial discrimination in drug policy, recognising the importance of harm reduction for the right to health, protecting Indigenous rights, and promoting engagement by UN human rights bodies in drug policy debates.
UNODC provides insights into a booming market, highlighting a 35% increase in the global production of cocaine following an initial slowdown caused by the COVID-19 pandemic.
Czechia stresses the importance of an evidence-based, integrated, balanced drug policies rooted in the freedom of citizens, the protection of human rights, dignity and the rule of law.
Ghana discusses the first ever National Dialogue on the International Guidelines on Human Rights and Drug Policy, including identifying human rights priorities and integrating them in the national plans for reform.
HRI's twelfth report documents the drastic increase of drug-related executions that have taken place over the course of 2022, the inadequate responses of institutional actors, and the robust resistance of civil society.
The INCB reviews the functioning of the international drug control system, dedicating a thematic chapter to the analysis of the trend to legalise the non-medical use of cannabis.
The ICJ, with UNAIDS and the OHCHR, outline a human rights-based approach to laws criminalising conduct in relation to sex, drug use, HIV, sexual and reproductive health, homelessness and poverty.
Pamplin et al. argue that the persistence of a broader, structurally racist environment of criminalisation undermines the public health–oriented policy changes made in some US states through 'Good Samaritan Laws'.
The Global Fund is the largest funder of harm reduction services in low-and-middle income countries and Grant Cycle 7 (2023-2025) is an important opportunity for countries to access vital funding.
É de Lei documents the escalation of police violence during and after the COVID-19 lockdown period, as well as the strategies of harm reduction and community mobilisation to resist and fight for the rights of the people in the area.
The Review Panel found that since its establishment in 2018, Richmond's supervised injecting facility has reduced overdose deaths and harm, and provided a gateway to health and social services, among other successes.
